A Clinical Study of [225Ac]Ac-FAPI-XT(XT117) Injection in Patients With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 14, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 1, 2026

Conditions

Advanced Solid Tumor

Interventions

DRUG

225Ac-FAPI-XT

Patients will receive \[225Ac\]Ac-FAPI-XT(XT117) administration at an interval of 6 weeks between each dose.

Trial Locations (1)

RECRUITING

Cancer Hospital of Shandong First Medical University, Jinan

All Listed Sponsors

lead

Xiaorong Sun

OTHER